knowledge -WSS

knowledge

author：hotspot 2025-09-30 15:17:12 - browse：79766

Illustration of a laptop on top of a TV with a hand sticking out, holding a newspaper. -- coverage from STAT — Adobe

WASHINGTON – If you live in this city, you’re probably awash in pharmacy benefit manager ads — whether you’re listening to an NPR podcast, reading the New York Times, streaming “Yellowstone,” or watching the U.S. Open Golf Championships. It doesn’t matter if it’s 5 a.m., primetime, or 11 p.m.; in between ads for dog joint supplements and the “Barbie” movie, you will inevitably learn about these middlemen of the prescription drug market.

Ads eviscerating and glorifying PBMs have been around for years. But they’ve intensified over the past three months as Congress scrutinizes PBMs’ role in shaping high drug prices. Over a half-dozen U.S. House and Senate Committees have started investigating PBMs, advancing bipartisan legislation to increase transparency in the industry; ban PBMs from charging more for a drug than what they pay (and pocketing the difference); and require them to pass all fees, rebates, and other payments they receive to insurers.

Lobbying groups have responded to this legislative push with dueling campaigns in the court of public opinion. On one side is the Pharmaceutical Care Management Association, the trade association representing PBMs, which argues that pharmaceutical companies are responsible for high drug prices. On the other side is the industry group PhRMA, which points the finger right back, saying that PBMs are really to blame. Both trade associations have launched ad campaigns worth millions of dollars, blanketing TV, radio, social media, print, and beyond.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Alkermes shareholders re

leisure time

hotspot

WSS

How one medical school became remarkably diverse

St. Louis police protesters begin picking up checks in $4.9 million settlement

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

At least 13 dead in Texas as scorching temps continue

Medical leaders decry Supreme Court decision on affirmative action

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

hotspot

knowledge

Wikipedia

Medicare details structure of new drug price negotiation program

Election results set back Medicaid expansion plans

Apple is now the first public company to be valued at $3 trillion

Apple is now the first public company to be valued at $3 trillion

Hepatitis C has a cure — but many Americans still lack access to it

Peter Hotez and the public health issue of online harassment

DIEP, the 'gold standard' of breast reconstruction, is under threat

After affirmative action ruling, medical educators look to 'holistic review'

The cancer drug shortage isn’t new — and neither are the solutions

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

Wikipedia

Sage considers ways to reduce costs following FDA rejection

What does generative AI mean for health care? We asked experts

Continuity nursing helped my family in our darkest PICU moments

Restaurant meals are packed with calories, and we still keep eating them

Paxlovid rebound happens. Why and to whom are still a mystery

Novavax promises a turnaround & Lilly roils the obesity market

focus

leisure time

hotspot

hotspot